Discover the full record of transactions filed by Cook Jennifer E., 董事. Officer active across 3 companies, notably Denali Therapeutics Inc.. In total, 33 disclosures have been recorded. Breakdown: 0 buy · 10 sells. Total volume traded: €11.7m. History available since 1 June 2021. The latest transaction was disclosed on 5 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Cook Jennifer E.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Jennifer E. Cook, Administrateur, is linked to BridgeBio Pharma, Inc., Denali Therapeutics Inc. and Jazz Pharmaceuticals plc as a Director. She has 32 filings in total, and across the recent sample of 32 filings, the reported activity shows sales of EUR 11,693,973 between 2021-06-03 and 2026-07-13, with the modal transaction nature listed as Attribution.